These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 19068396)
21. False positive labeling of prostate cancer with high molecular weight cytokeratin: p63 a more specific immunomarker for basal cells. Ali TZ; Epstein JI Am J Surg Pathol; 2008 Dec; 32(12):1890-5. PubMed ID: 18813120 [TBL] [Abstract][Full Text] [Related]
22. Is triple immunostaining with 34betaE12, p63, and racemase in prostate cancer advantageous? A tissue microarray study. Ng VW; Koh M; Tan SY; Tan PH Am J Clin Pathol; 2007 Feb; 127(2):248-53. PubMed ID: 17210521 [TBL] [Abstract][Full Text] [Related]
23. The prostate-specific G-protein coupled receptors PSGR and PSGR2 are prostate cancer biomarkers that are complementary to alpha-methylacyl-CoA racemase. Wang J; Weng J; Cai Y; Penland R; Liu M; Ittmann M Prostate; 2006 Jun; 66(8):847-57. PubMed ID: 16491480 [TBL] [Abstract][Full Text] [Related]
24. p63/AMACR antibody cocktail restaining of prostate needle biopsy tissues after transfer to charged slides: a viable approach in the diagnosis of small atypical foci that are lost on block sectioning. Hameed O; Humphrey PA Am J Clin Pathol; 2005 Nov; 124(5):708-15. PubMed ID: 16203278 [TBL] [Abstract][Full Text] [Related]
25. Alpha-methylacyl-CoA racemase: a multi-institutional study of a new prostate cancer marker. Jiang Z; Wu CL; Woda BA; Iczkowski KA; Chu PG; Tretiakova MS; Young RH; Weiss LM; Blute RD; Brendler CB; Krausz T; Xu JC; Rock KL; Amin MB; Yang XJ Histopathology; 2004 Sep; 45(3):218-25. PubMed ID: 15330799 [TBL] [Abstract][Full Text] [Related]
26. Partial atrophy on prostate needle biopsy cores: a morphologic and immunohistochemical study. Wang W; Sun X; Epstein JI Am J Surg Pathol; 2008 Jun; 32(6):851-7. PubMed ID: 18408595 [TBL] [Abstract][Full Text] [Related]
27. Discovery and clinical application of a novel prostate cancer marker: alpha-methylacyl CoA racemase (P504S). Jiang Z; Woda BA; Wu CL; Yang XJ Am J Clin Pathol; 2004 Aug; 122(2):275-89. PubMed ID: 15323145 [TBL] [Abstract][Full Text] [Related]
29. How often does alpha-methylacyl-CoA-racemase contribute to resolving an atypical diagnosis on prostate needle biopsy beyond that provided by basal cell markers? Zhou M; Aydin H; Kanane H; Epstein JI Am J Surg Pathol; 2004 Feb; 28(2):239-43. PubMed ID: 15043314 [TBL] [Abstract][Full Text] [Related]
30. Performance comparison of anti-p504s (SP116) Rabbit Monoclonal Primary Antibody vs. Monoclonal Rabbit Anti-Human AMACR clone 13H4 when duplexed with VENTANA Basal Cell Cocktail (34βE12+p63) as a diagnostic aid for prostatic adenocarcinoma using immunohistochemistry. Lindner V; Waydelich A; Chen CC; Jones C; Stratton SP Virchows Arch; 2021 Aug; 479(2):337-343. PubMed ID: 33811532 [TBL] [Abstract][Full Text] [Related]
31. Prognostic significance of alpha-methylacyl-coA racemase among men with high grade prostatic intraepithelial neoplasia in prostate biopsies. Stewart J; Fleshner N; Cole H; Toi A; Sweet J J Urol; 2008 May; 179(5):1751-5; discussion 1755. PubMed ID: 18343427 [TBL] [Abstract][Full Text] [Related]
32. [Value of the antibody cocktail anti p63 + anti p504s for the diagnosis of prostatic cancer]. Molinié V; Hervé JM; Lebret T; Lugagne-Delpon PM; Saporta F; Yonneau L; Botto H; Baglin AC Ann Pathol; 2004 Feb; 24(1):6-16. PubMed ID: 15192532 [TBL] [Abstract][Full Text] [Related]
33. Aberrant diffuse expression of p63 in adenocarcinoma of the prostate on needle biopsy and radical prostatectomy: report of 21 cases. Osunkoya AO; Hansel DE; Sun X; Netto GJ; Epstein JI Am J Surg Pathol; 2008 Mar; 32(3):461-7. PubMed ID: 18300803 [TBL] [Abstract][Full Text] [Related]
34. Alpha-methylacyl coenzyme A racemase immunoreactivity in partial atrophy of the prostate. Adley BP; Yang XJ Am J Clin Pathol; 2006 Dec; 126(6):849-55. PubMed ID: 17074684 [TBL] [Abstract][Full Text] [Related]
36. Virtual microscopy in prostate histopathology: simultaneous viewing of biopsies stained sequentially with hematoxylin and eosin, and alpha-methylacyl-coenzyme A racemase/p63 immunohistochemistry. Helin HO; Lundin ME; Laakso M; Lundin J; Helin HJ; Isola J J Urol; 2006 Feb; 175(2):495-9. PubMed ID: 16406979 [TBL] [Abstract][Full Text] [Related]
37. Evaluation of routine application of P504S, 34betaE12 and p63 immunostaining on 250 prostate needle biopsy specimens. Pavlakis K; Stravodimos K; Kapetanakis T; Gregorakis A; Athanassiadou S; Tzaida O; Constantinides C Int Urol Nephrol; 2010 Jun; 42(2):325-30. PubMed ID: 19655267 [TBL] [Abstract][Full Text] [Related]
38. Application of combined immunohistochemical panel of AMACR(P504S)/p63 cocktail, cytokeratin 5 and D2-40 to atypical glands in prostatic needle biopsy. Kuroda N Malays J Pathol; 2014 Dec; 36(3):169-73. PubMed ID: 25500515 [TBL] [Abstract][Full Text] [Related]
39. Using an AMACR (P504S)/34betaE12/p63 cocktail for the detection of small focal prostate carcinoma in needle biopsy specimens. Jiang Z; Li C; Fischer A; Dresser K; Woda BA Am J Clin Pathol; 2005 Feb; 123(2):231-6. PubMed ID: 15842047 [TBL] [Abstract][Full Text] [Related]
40. P63 and p504s cocktail is useful in ambiguous lesions of the prostate. Molinié V; Hervé JM; Lugagne PM; Baglin AC Histopathology; 2004 Apr; 44(4):403-4. PubMed ID: 15049912 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]